Jefferies raises Lonza Group PT after $1.2bn Roche site acquisition By Investing.com
© Reuters. On Monday, Jefferies maintained a Buy rating on Lonza Group AG (LONN:SW) (OTC: LZAGY) and increased its price ...
© Reuters. On Monday, Jefferies maintained a Buy rating on Lonza Group AG (LONN:SW) (OTC: LZAGY) and increased its price ...
Michael Vi/iStock Editorial via Getty Images Developers of a drug class called anti-TIGIT immunotherapies traded higher in pre-market trading on ...
yuelan Roche (OTCQX:RHHBY) (OTCQX:RHHBF) said its oral drug fenebrutinib met the main and secondary goals of a phase 2 trial ...
Key Takeaways Kyle Roche, a lawyer involved in several crypto legal cases, officially left the law firm Roche Freedman today. ...
Marcelo Ricardo Daros AbbVie (NYSE:ABBV), Roche (OTCQX:RHHBY), and Regeneron Prescription drugs (NASDAQ:REGN), which market and/or are creating new age-related macular ...
© Reuters. FILE PHOTO: The brand of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland January 30, ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.